| Green Eye Institute Pa | |
| 102 E Hospital Dr, Hattiesburg, Mississippi 39402 | |
| (601) 268-5144 |
| Name | Green Eye Institute Pa |
|---|---|
| Organization Name | Green Eye Institute Pa |
| Location | 102 E Hospital Dr, Hattiesburg, Mississippi 39402 |
| Type | Supplier |
| Phone | (601) 268-5144 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center researchers.
Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication for Bayer's Kogenate® FS antihemophilic factor VIII (recombinant), for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten offering of 6,460,672 shares of its common stock at a price of $4.35 per share. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $26.2 million. All of the shares are being sold by Idenix.
A new Kaiser Family Foundation poll finds views generally reflect partisan affiliations, and, overall, the the public remains split in its view of the 2010 health law. A slim majority (54 percent) says they are tired of hearing lawmakers fight over the law and would like the debate to move on to other topics.
› Verified 1 days ago
News Archive
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center researchers.
Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication for Bayer's Kogenate® FS antihemophilic factor VIII (recombinant), for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten offering of 6,460,672 shares of its common stock at a price of $4.35 per share. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $26.2 million. All of the shares are being sold by Idenix.
A new Kaiser Family Foundation poll finds views generally reflect partisan affiliations, and, overall, the the public remains split in its view of the 2010 health law. A slim majority (54 percent) says they are tired of hearing lawmakers fight over the law and would like the debate to move on to other topics.
› Verified 1 days ago
A & A Home Health Equipment Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1608 Broadway Dr 30, Hattiesburg, Mississippi 39402 Phone: (601) 261-3936 | |
Pine Belt Medical Equipment Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6375 U S Highway 98, Hattiesburg, Mississippi 39402 Phone: (601) 268-1422 | |
Aerocare Home Medical, Inc. Type: DME Supplier - Oxygen Equipment & Supplies Location: 6555 U S Highway 98, Hattiesburg, Mississippi 39402 Phone: (601) 450-4612 | |
Grace Healthcare Type: Medicare Supplier Location: 112 S 27th Ave, Hattiesburg, Mississippi 39401 Phone: (601) 450-4612 | |
Eye Works Type: Eyewear Supplier (Equipment, not the service) Location: 3901 Hardy St, Hattiesburg, Mississippi 39402 Phone: (601) 261-2221 |